Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.024 | 0.7 |